Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
Pharmaceutical companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in JapanLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under 2 spellings of its name, each linked to the record.
As of Nov 13, 2026, FDA's public records list Hisamitsu Pharmaceutical and its 3 subsidiaries with 58 drug recalls and 13 drug applications. The most recent is a drug recall dated Mar 31, 2020: Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr), 3….
Group recordsLabelled by a language model (which subsidiaries belong to the group) from the firm's FDA names. It is not an FDA field.: 71, 4 entities
Drug recalls: 58
Drug applications: 13
Records by Year
Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date, Hisamitsu Pharmaceutical and its 3 subsidiaries
How to read this
A hatched bar is a year that is not over, so its count covers only part of the year.
82017Records8
720182018Records7vs 2017−1
12019Records1vs 2018−6
820202020Records8vs 2019+7
102021Records10vs 2020+2
420222022Records4vs 2021−6
42023Records4vs 2022+0
120242024Records1vs 2023−3
02025Records0vs 2024−1
020262026 to dateRecords0
Latest Records
Newest first across sources; each opens the record
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.How this page is built
